Additionally, in our study, important clinical variables that may affect redox biomarkers, such as diabetes, hypertension, dyslipidemia, statin or ACE inhibitor use, which may affect oxidative stress biomarkers, may be present in the disease group. The gene discussed is ACE; the disease is metabolic syndrome.